MEDNAX INC (MD)

symbol lookup

Follow MD via My Validea and receive an email alert whenever any of our strategies changes its rating.

Get Started
Score: 71/100
Analysis based upon 2/19/2020 closing price.
Latest Close: $26.59 Market Cap ($ mil): $2,242 Sector: Healthcare Industry: Healthcare Facilities 52 Week High: $36.81 52 Week Low: $19.93 Relative Strength: 26 Twelve Minus One Return: -23.7%
PE Ratio: N/A Price/Sales: 0.6 Price/Book: 1.5 Price/Cash Flow: 6.1 EV/EBITDA: 8.40 Yield: N/A Shareholder Yield: 2.21% Value Composite Percentile: 21
Return on Equity: -50.0% Return on Tangible Capital: 46.0% Return on Invested Capital: N/A WACC: N/A Debt/Equity: 1.31 LT EPS Growth: -0.5% LT Sales Growth: 10.4% Quality Composite Percentile: 63
MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of November 26, 2018, the Company's national network consisted of over 4,225 physicians in all 50 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. As of December 31, 2016, the Company had 270 affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Report Card - Value Investor

Guru Criteria: Benjamin Graham  
SECTOR:PASS
SALES:PASS
CURRENT RATIO:FAIL
LONG-TERM DEBT IN RELATION TO NET CURRENT ASSETS:FAIL
LONG-TERM EPS GROWTH:PASS
P/E RATIO:PASS
PRICE/BOOK RATIO:PASS

Detailed Analysis

Get a full analysis of MD using this and 11 other strategies of investment legends.

Start Your Free Trial